World Menopause and Cancer Day Launch

WORLD MENOPAUSE AND CANCER DAY

18th September 2025 at The Royal Society of Arts London

In a world full of awareness days, one vital community has been left behind – until now. This year marks the inaugural launch of World Menopause and Cancer Day, a global campaign led by the UK’s leading organisation supporting cancer survivors navigating treatment-induced menopause: Menopause and Cancer.

The campaign, launching in London and reaching globally, will unite voices across oncology, menopause care, research, and survivor communities. The aim: to finally shine a spotlight on the often-overlooked experiences of cancer patients thrown into menopause due to life-saving treatments.

“Cancer changes everything — including how and when you go through menopause. It’s time we stop treating this as an afterthought,” says Dani Binnington, cancer survivor and founder of Menopause and Cancer. “We need tailored support, research funding, and clinical awareness — and we need to bring this conversation to the main stage. That’s what World Menopause and Cancer Day is all about.”

A First-of-Its-Kind Global Initiative

While there are awareness days for almost every cause, World Menopause and Cancer Day is the first to directly highlight the unique intersection of cancer treatment and menopause.

The evening will feature:

• Bringing together leading voices in the NHS and private sector
• Celebration presentation with oncologists, menopause specialists, and experts in their fields. A special thank you to Dr. Macbeth and Mr. Talaulikar for their contributions.
• Calls for increased research into treatment-induced menopause
• Global patient stories highlighting the real impact of this overlooked health issue

This day is not just symbolic — it’s a rallying cry for better care, more visibility, and system-wide change.

Why?

Globally, approximately 9.2 million women were diagnosed with cancer in 2022, with breast cancer being the most prevalent, accounting for about 2.3 million new cases. In the UK alone, over 186,000 women are diagnosed with cancer annually. Life-saving treatments such as chemotherapy, radiotherapy, surgery, and hormone therapy can induce sudden and often permanent menopause in 40% of women under 40 and 70–90% of women over 40, leading to symptoms that may persist for decades.

Alarmingly, over 90% of those experiencing treatment-induced menopause receive no information or support on managing their symptoms or understanding available hormonal and non-hormonal treatment options. This gap stems from a historical lack of training among medical professionals and widespread unawareness. The compounded physical and emotional challenges leave people feeling isolated and unheard, with many reporting that managing menopause after cancer is more difficult than the cancer treatments themselves. Apart from the debilitating symptoms, without proper care, these individuals face increased risks of chronic conditions like osteoporosis, cardiovascular issues, and severe gynaecological problems. It's imperative that we address this oversight and provide the necessary support to those affected.

About Menopause and Cancer

Menopause and Cancer is the UK’s leading non-profit organisation dedicated to supporting people experiencing treatment-induced menopause after cancer. Founded by advocate and survivor Dani Binnington, the organisation provides evidence-based information, peer support, education, and advocacy, ensuring no one has to face this complex journey alone.

Thank you to The RSA for kindly hosting us.